イーサ Company Profile

The domestic acceptance of eCTD version 4.0 has begun, and how is your preparation for the viewer, which is essential for package reviews during drug applications? More companies are increasing their preparations to comply with the mandatory implementation of eCTD version 4.0 starting from April 1, 2026. The "eP²AS VUE" that we are introducing this time includes standard viewer functions for eCTD version 4.0 and application packages to the FDA, in addition to the conventional eCTD version 3.2.2. It is also a secure cloud-based solution that can be used as a management and operation system for storing, archiving, sharing, viewing, and reviewing application packages on a DMS or local server under detailed access control. We encourage you to take this opportunity to participate in the webinar and experience the next-generation viewer through a demonstration!